Alembic Pharmaceuticals has informed that Alembic Global Holding SA, wholly owned subsidiary of Alembic Pharmaceuticals (Company) has subscribed in a new entity named TicTwo Therapeutics Inc. The disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the aforesaid acquisition is enclosed as Annexure -I.
The above information is a part of company’s filings submitted to BSE.